SCHEMBL7993249

SCHEMBL7993249

Cc1nc(Cc2ccccc2Cl)[nH]c1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ MAPT P10636 2/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ ALDH1A1 P00352 1/20 0.42
▸ ADORA2A P29274 1/20 0.41
▸ ADORA1 P30542 1/20 0.41
▸ PTGS2 P35354 1/20 0.40
▸ PDE3B Q13370 1/20 0.40
▸ PDE3A Q14432 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ TAAR1 Q96RJ0 1/20 0.40
▸ ALKBH3 Q96Q83 1/20 0.39
▸ ENPP1 P22413 1/20 0.39
▸ PNP P00491 1/20 0.38
▸ AR P10275 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11298020 0.83 EGFR (0.47) SMN1; SMN2ALDH1A1ARMEN1GAA
SCHEMBL2864047 0.81 KDM4E (0.51) LMNASMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL27967775 0.81 LMNA (0.48) LMNASMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL2870405 0.81 LMNA (0.51) LMNASMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL2869028 0.79 KDM4E (0.46) LMNASMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL2867291 0.78 KDM4E (0.48) LMNASMN1; SMN2MAPTKDM4EADORA2A
SCHEMBL28812702 0.78 MAPT (0.48) LMNASMN1; SMN2MAPTKDM4EADORA2A
SCHEMBL2861970 0.78 KDM4E (0.45) LMNASMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL14334455 0.77 MAPT (0.45) LMNASMN1; SMN2MAPTKDM4EALDH1A1
SCHEMBL31305487 0.77 LMNA (0.44) LMNASMN1; SMN2MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001056995-A1 SUBSTITUTED IMIDAZOLES AS SELECTIVE MODULATORS OF BRADYKININ B2 RECEPTORS NUEROGEN CORPORATION (US) 2001-08-09 — — WO disclosed
Send feedback